Vertex Pharmaceuticals: UBS raises target price to $615 from $585
VRTX•UBS raised its target price for Vertex Pharmaceuticals to $615 from $585.
Related News
Treasure Global signs MOU to buy 51% stake in smart water metering firm for $38 million
TGL•
Portland General Electric Co: UBS cuts target price to $50 from $53
POR•
China, US agree to tariff cuts on $60 billion of goods including agriculture, household items
SPY•
Conagra Brands holds annual shareholder meeting
CAG•
US stocks on the move: WhiteHawk, Nvidia, Snowflake
SPY•